Recall alert: Relpax migraine medication recalled due to potential microbe contamination

Relpax recalls migraine medication over potential microbe exposure

Migraine sufferers who use Relpax may want to check their medicine cabinets.

Pfizer Inc., the manufacturer of the medication, along with the Food and Drug Administration have announced a recall of the treatment due to potential microbiological contamination.

Relpax is used to treat migraines with and without aura in adults, according to the FDA.

Content Continues Below

Two lots of 40 mg tablet packages could have Genus Pseudomonas or Burkholderia contamination and are labeled AR5407 and C4565.

If you take the medication and it is contaminated with the microorganisms, the bacteria could enter the bloodstream and could result in serious, life-threatening infections, the FDA said.

There is also a risk of gastrointestinal distress without a serious infection, but that discomfort is temporary, the FDA said.

Pharmacies and hospitals that have dispensed the affected medication have been instructed to inform their patients. If you have questions, you can call Stericycle Inc. at 877-225-9750 for details on how to return the medication and get reimbursement for the cost of the medication.